driver acceler
result guidanc consist januari pre-
announc beyond increment updat
roadmap leav us confid acceler remain
result in-lin pre-announc report revenu
reflect y/i growth point momentum acceler
consist pre-announc initi
estim largest beat sinc ipo us revenu y/i
line estim driven strong procedur volum growth
revenu rel stabl y/i consist
result gross margin beat estim point
resili level year despit broader spine price pressur opex
increas y/i adj litig expens mainli
driven invest hire surgeon train compani end
rep css increas total sale forc recal late januari
rais net primari equiti proce estim
ad year cash addit financi flexibl see
driver guidanc revenu guidanc y/i
unchang earli januari in-lin expect see
outlook see compon guidanc us revenu growth
revenu growth msd-hsd see guidanc
appropri conserv encourag manag taken
prudent approach year respect hire compani plan add
sale rep clinic support specialist css total commerci
increas y/i continu focu drive rep effici us
si-bon end activ surgeon us project
reach end y/i vs see modest
slowdown activ surgeon growth function rel conservat
priorit penetr exist account perform insignific
number procedur modestli work expand physician base
remain confid acceler referenc see
guidanc appropri conserv begin year expect upsid
driven base busi momentum discuss follow
signific year commerci expans y/i expect rep product
improv rev/rep see rate improv
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
compani rep css ratio nearli averag rev/rep rate reach
would impli upsid vs model despit posit
coverag decis go effect begin manag state
posit procedur tailwind alreadi seen like result cigna
patient previous receiv conserv therapi
elig sijf expect addit cover live modest
tailwind throughout year new patient reach conserv therapi
criteria becom elig sijf final discuss increas
physician payment key potenti upsid driver
manag suggest interest improv earli impact seen
along patient pull-through expect drive increment
interest perform procedur driver us procedur volum
momentum build throughout year
revenu deriv us therefor
see headwind busi said
manag discuss impact seen northern itali
procedur although region repres total sale
impact spread germani sale could result modestli
greater headwind compani manufactur
suppli exposur china see sort suppli disrupt
ifus bedrock decemb bedrock receiv ce mark europ
launch occur februari manag commentari suggest
product track along plan goal continu focus
garner addit interest si joint key opinion leader
respect guidanc convers suggest bedrock
materi compon revenu guidanc consist view
updat silvia trial see limit howev manag
state earli enrol track
ifus bone compani launch new product ifus bone
decemb us product enabl triangular technolog
surgeon interest implant bone conjunct
ifus procedur see product materi revenu driver
payor updat follow posit coverag decis decemb
see potenti addit larg commerci payor
begin cover mi sijf forecast addit payor
decis model guidanc conting upon addit payor
coverag note aetna like review coverag polici march
expect fall humama timelin
unclear note addit one larger commerci payor add
addit cover live
upcom launch beyond bedrock ifus bone manag
discuss two meaning product launch adult deform
trauma space schedul late earli increment detail
limit howev convers suggest product
insignific revenu driver
momentum build remain overweight follow three quarter rel
in-lin result throughout post largest quarterli beat
demonstr point momentum acceler see initi guidanc
prudent appropri conserv remain confid y/i top-line
acceler driven continu commerci invest heighten rep
effici expand physician payment expans surgeon train
remain overweight dcf-base price target impli
sale discuss discount high-growth smid-cap peer
notabl disconnect expect compress deliv
commerci execut post consist upsid guidanc
price target base dcf valuat assum wacc
model termin year oper margin similar spine compar price
target impli multipl base case sale premium core spine
compar given outsiz growth discount high growth smid cap devic peer
given acceler busi yet proven
advantag penetr underserv
sacroiliac joint fusion market
differenti surgic implant ifus
implant random control
busi near point
inect given momentum
focu surgeon educ iii sale
forc expans contribut
view descript risk reward theme
si-bon abl gain posit coverag
decis larg commerci payor
develop addit exclus contract
physician reimburs doubl level
compar open si joint fusion drive
adopt procedur growth faster
penetr revenu
signic invest commerci
expans surgeon train drive
top-line acceler
increas physician payment rate result
increment interest surgeon
perform procedur si-bon abl
next sever year increas total
ifus cover live
si-bon unsuccess gener
addit coverag commerci payor
physician interest remain mute given
payment rate still compar
increas competit si-bon
achiev market penetr
addit pt penetr drive
pt growth
traction commerci payor present
opportun expand cover live
attract gross margin prole
tam expans deform trauma
view explan region hierarchi
commerci momentum lead materi
surgeon interest ignit greater
inabl gain reimburs coverag
rel low reimburs vs
si joint fusion market develop
expect oper small nich market
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
million except ep
properti plant equip net
chang allow doubt account
chang fair valu conv prefer warrant
write-off pp
amort debt discount
chang work capit
oper
invest
proce stock option exercis
financ
effect foreign exchang rate
